|
⚲
|
| Keyboard |
| Sharp John P
✚
|
|
|---|---|
| CIK # | 0001342894 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001342894] | |
| 4 | [0001342894] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sharp John P | |
| Skye Bioscience Inc | |
| PhaseBio Pharmaceuticals Inc | |
| Ligand Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-20 | Grant | 6,026 | $0.68 | 4,098 |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Unit · derivative
|
2022-02-24 | Grant | 24,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2022-02-24 | Grant | 115,500 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-11-19 | Grant | 2,017 | $2.01 | 4,054 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2021-11-03 | Option exercise | 7,500 | $1.68 | 12,600 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-11-03 | Option exercise | 7,500 | $1.68 | 12,600 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-08-03 | Grant | 7,500 | $1.68 | 12,600 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-05-20 | Grant | 1,419 | $2.80 | 3,973 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2021-02-05 | Grant | 76,500 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2020-11-20 | Grant | 1,305 | $3.00 | 3,915 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-08-14 | Option exercise | 5,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2020-08-14 | Option exercise | 5,000 | $1.69 | 8,450 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 100,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2019-08-21 | Option exercise | 5,000 | $1.44 | 7,200 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2019-08-21 | Option exercise | 10,000 | $1.69 | 16,900 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2019-08-21 | Option exercise | 10,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2019-08-21 | Option exercise | 5,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2019-05-22 | Option exercise | 15,000 | $1.69 | 25,350 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2019-05-22 | Option exercise | 15,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2019-02-27 | Grant | 100,000 | $0.00 | |
| showing 20 of 73 most recent transactions | |||||